This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weinberg, W. C. Articles by Yuspa, S. H. Search for Related Content PubMed PubMed Citation Articles by Weinberg, W. C. Articles by Yuspa, S. H.

Genetic Deletion of p21^WAF1 Enhances Papilloma Formation but not Malignant Conversion in Experimental Mouse Skin Carcinogenesis

Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research [W. C. W., A. S.], Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute [D. L. M., E. F-S., H. H., S. H. Y.], and Laboratory of Biochemistry and Metabolism, National Institute of Diabetes and Digestive and Kidney Disorders [C. D.], NIH, Bethesda, Maryland 20892, and ROW Sciences, Inc., Rockville, Maryland 20878 [E. S., E. M.]

Tumor suppression by p53 is believed to reside in its ability to regulate gene transcription, including up-regulation of p21^WAF1. In p53(-/-) mice, chemical- or oncogene-induced skin tumors undergo accelerated malignant conversion. To determine the contribution of the p21^WAF1 gene product to epidermal carcinogenesis, animals +/+, + /-, and -/- for a null mutation in the p21^WAF1 gene were treated once with 25 nmol 7,12-dimethylbenz[a]anthracene, followed by 5 µg of TPA two times/week for 20 weeks. Papilloma frequency was higher in the p21^WAF1-deficient mice. However, the frequency of malignant conversion was similar among all three genotypes. After TPA treatment, all genotypes developed epidermal hyperplasia, although the labeling index was lower in p21^WAF1 (-/-) epidermis compared with p21^WAF1 (+/+). Furthermore, the expression of differentiation markers was the same across genotypes in untreated or TPA-treated epidermis. Similar frequencies of malignant conversion were also observed in an in vitro assay. Thus, p21^WAF1 suppresses early stages of papilloma formation but not malignant progression in mouse skin carcinogenesis, and decreased levels of p21^WAF1 do not account for the enhanced malignant conversion of p53 null epidermal tumors.

This article has been cited by other articles:

				J. Shen, R. J. Barrios, and A. K. Jaiswal Inactivation of the Quinone Oxidoreductases NQO1 and NQO2 Strongly Elevates the Incidence and Multiplicity of Chemically Induced Skin Tumors Cancer Res., February 1, 2010; 70(3): 1006 - 1014. [Abstract] [Full Text] [PDF]

				M.-K. Shin, S. Balsitis, T. Brake, and P. F. Lambert Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis Cancer Res., July 15, 2009; 69(14): 5656 - 5663. [Abstract] [Full Text] [PDF]

				T. Tanaka, K. S. Suh, A. M. Lo, and L. M. De Luca p21WAF1/CIP1 Is a Common Transcriptional Target of Retinoid Receptors: PLEIOTROPIC REGULATORY MECHANISM THROUGH RETINOIC ACID RECEPTOR (RAR)/RETINOID X RECEPTOR (RXR) HETERODIMER AND RXR/RXR HOMODIMER J. Biol. Chem., October 12, 2007; 282(41): 29987 - 29997. [Abstract] [Full Text] [PDF]

				N. Ohtani, Y. Imamura, K. Yamakoshi, F. Hirota, R. Nakayama, Y. Kubo, N. Ishimaru, A. Takahashi, A. Hirao, T. Shimizu, et al. Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals PNAS, September 18, 2007; 104(38): 15034 - 15039. [Abstract] [Full Text] [PDF]

				H. E. van Gijssel, T. A. Leil, W. C. Weinberg, R. L. Divi, O. A. Olivero, and M. C. Poirier Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin Mutagenesis, January 1, 2007; 22(1): 49 - 54. [Abstract] [Full Text] [PDF]

				A. Krones-Herzig, S. Mittal, K. Yule, H. Liang, C. English, R. Urcis, T. Soni, E. D. Adamson, and D. Mercola Early Growth Response 1 Acts as a Tumor Suppressor In vivo and In vitro via Regulation of p53 Cancer Res., June 15, 2005; 65(12): 5133 - 5143. [Abstract] [Full Text] [PDF]

				V. Devgan, C. Mammucari, S. E. Millar, C. Brisken, and G. P. Dotto p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation Genes & Dev., June 15, 2005; 19(12): 1485 - 1495. [Abstract] [Full Text] [PDF]

				F. Capozza, T. M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M. P. Lisanti Absence of Caveolin-1 Sensitizes Mouse Skin to Carcinogen-Induced Epidermal Hyperplasia and Tumor Formation Am. J. Pathol., June 1, 2003; 162(6): 2029 - 2039. [Abstract] [Full Text] [PDF]

				W. C. Weinberg and M. F. Denning P21WAF1 CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 453 - 464. [Abstract] [Full Text] [PDF]

				H. Oh, C. Mammucari, A. Nenci, S. Cabodi, S. N. Cohen, and G. P. Dotto Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1 PNAS, April 16, 2002; 99(8): 5430 - 5435. [Abstract] [Full Text] [PDF]

				G. W. McLean, K. Brown, M. I. Arbuckle, A. W. Wyke, T. Pikkarainen, E. Ruoslahti, and M. C. Frame Decreased Focal Adhesion Kinase Suppresses Papilloma Formation during Experimental Mouse Skin Carcinogenesis Cancer Res., December 1, 2001; 61(23): 8385 - 8389. [Abstract] [Full Text] [PDF]

				J. M. Paramio, C. Segrelles, S. Ruiz, J. Martin-Caballero, A. Page, J. Martinez, M. Serrano, and J. L. Jorcano The ink4a/arf Tumor Suppressors Cooperate with p21cip1/waf in the Processes of Mouse Epidermal Differentiation, Senescence, and Carcinogenesis J. Biol. Chem., November 16, 2001; 276(47): 44203 - 44211. [Abstract] [Full Text] [PDF]

				M J Schwerer, A Sailer, K Kraft, K Baczako, and H Maier Patterns of p21waf1/cip1 expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas J. Clin. Pathol., November 1, 2001; 54(11): 871 - 876. [Abstract] [Full Text] [PDF]

				J. Martin-Caballero, J. M. Flores, P. Garcia-Palencia, and M. Serrano Tumor Susceptibility of p21Waf1/Cip1-deficient Mice Cancer Res., August 1, 2001; 61(16): 6234 - 6238. [Abstract] [Full Text] [PDF]

				Q. A. Khan and A. Dipple Diverse chemical carcinogens fail to induce G1 arrest in MCF-7 cells Carcinogenesis, August 1, 2000; 21(8): 1611 - 1618. [Abstract] [Full Text] [PDF]

				S. Mueller, E. Cadenas, and A. H. Schönthal p21WAF1 Regulates Anchorage-independent Growth of HCT116 Colon Carcinoma Cells via E-Cadherin Expression Cancer Res., January 1, 2000; 60(1): 156 - 163. [Abstract] [Full Text]

				G. I. Topley, R. Okuyama, J. G. Gonzales, C. Conti, and G. P. Dotto p21WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential PNAS, August 3, 1999; 96(16): 9089 - 9094. [Abstract] [Full Text] [PDF]

				H. Oh, C. Mammucari, A. Nenci, S. Cabodi, S. N. Cohen, and G. P. Dotto Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1 PNAS, April 16, 2002; 99(8): 5430 - 5435. [Abstract] [Full Text] [PDF]